Chongqing Sokon Industry Group Stock (09927): As of October 12, a total of 17.5357 million A shares have been repurchased.
Seres (09927) announced that as of October 12, 2026, the company had cumulatively repurchased 17.5357 million shares through the Shanghai Stock Exchange system by way of centralized bidding, accounting for approximately 1.01% of the company's total share capital, an increase of approximately 0.11% compared with the previous disclosure. The highest repurchase price was RMB 91.00 per share and the lowest was RMB 43.99 per share, with a total amount paid of RMB 983 million (excluding transaction fees).
Chongqing Sokon Industry Group Stock (09927) announced that as of October 12, 2026, the company had cumulatively repurchased 17.5357 million shares through the Shanghai Stock Exchange system via centralized bidding, accounting for approximately 1.01% of the company's total share capital, an increase of approximately 0.11% compared with the previous disclosure. The highest repurchase price was RMB 91.00 per share, and the lowest was RMB 43.99 per share, with a total payment of RMB 983 million (excluding transaction fees).
Related Articles
CHINANEWTOWN (01278): As of the end of September, the total investment portfolio of fixed-income projects was approximately RMB 3.073 billion.
Sichuan Biokin Pharmaceutical (688506.SH): Yizekang new indication included in priority review process
ASIASEC PPT (00271) proposes a "10-into-1" share consolidation, followed by a rights issue on a "1-for-1" basis.
CHINANEWTOWN (01278): As of the end of September, the total investment portfolio of fixed-income projects was approximately RMB 3.073 billion.
Sichuan Biokin Pharmaceutical (688506.SH): Yizekang new indication included in priority review process
ASIASEC PPT (00271) proposes a "10-into-1" share consolidation, followed by a rights issue on a "1-for-1" basis.
